ENG

제품 파이프라인

HBV Vaccine
(3rd generation prophylactic)

Indication: Prevention of Hepatitis B

  1. Research
    O
  2. Pre-Clinical
    O
  3. Phase I
    O
  4. Phase II
    O
  5. Phase III

Remarks: Phase IIb Planning
(Application: non-responder, high risk group, 2 dose vaccine)

Adjuvanted HBV Vaccine (Therapeutic)

Indication: Treatment of Chronic Hepatitis

  1. Research
    O
  2. Pre-Clinical
    O
  3. Phase I
    O
  4. Phase II
    O
  5. Phase III

Remarks: Phase I/IIa On going 4 Cohorts: 20 or 40 μg/dose for 3 or 6 injections in each dose

VZV Vaccine (Shingles)

Indication: Prevention of Herpes Zoster (Shingles)

  1. Research
    O
  2. Pre-Clinical
    O
  3. Phase I
    O
  4. Phase II
  5. Phase III

Remarks: Phase I On going

Influenza Vaccine

Indication: Prevention of seasonal Flu (high risk group)

  1. Research
    O
  2. Pre-Clinical
  3. Phase I
  4. Phase II
  5. Phase III

Remarks: Feasibility Study

Recombinant MBL

Indication: Suppression of infectious disease

  1. Research
    O
  2. Pre-Clinical
  3. Phase I
  4. Phase II
  5. Phase III

Remarks: Feasibility Study

TB Vaccine

Indication: Suppression of infectious disease

  1. Research
    O
  2. Pre-Clinical
  3. Phase I
  4. Phase II
  5. Phase III

Remarks: Feasibility Study

Cancer Vaccine

Indication: Therapeutic vaccine

  1. Research
    O
  2. Pre-Clinical
  3. Phase I
  4. Phase II
  5. Phase III

Remarks: Feasibility Study

Product Indication Research Pre-Clinical Phase Remarks
I II III
HBV Vaccine
(3rd generation prophylactic)		 Prevention of Hepatitis B
O
O
O
O
 Phase IIb Planning
(Application: non-responder, high risk group, 2 dose vaccine)
Adjuvanted HBV Vaccine
(Therapeutic)		 Treatment of Chronic Hepatitis B
O
O
O
O
 Phase I/IIa On going 4 Cohorts: 20 or 40 μg/dose for 3 or 6 injections in each dose
VZV Vaccine (Shingles) Prevention of Herpes Zoster (Shingles)
O
O
O
 Phase I On going
Influenza Vaccine Prevention of seasonal Flu (high risk group)
O
 Feasibility Study
Recombinant MBL Suppression of infectious disease
O
 Feasibility Study
TB Vaccine Boosting vaccine
O
 Feasibility Study
Cancer Vaccine Therapeutic vaccine
O
 Feasibility Study